Status:
COMPLETED
Intraoperative Adverse Events in Robotic Radical Gastrectomy for Gastric Cancer
Lead Sponsor:
Fujian Medical University
Conditions:
Gastric Cancer
Eligibility:
All Genders
Brief Summary
Surgical quality control is a crucial determinant of evaluating the tumor efficacy. We assess the ClassIntra grade for quality control and oncological outcomes of robotic radical surgery for gastric c...
Detailed Description
Gastric cancer (GC) is the fifth most common malignant tumor worldwide and the fourth leading cause of cancer-related deaths. Surgery remains the cornerstone of GC treatment, and there is a significan...
Eligibility Criteria
Inclusion
- Patients diagnosed with gastric adenocarcinoma through pathology;
- Preoperative chest radiograph, abdominal ultrasonogram, and full abdominal CT examination showed no distant metastasis to the liver, lungs, or abdominal cavity;
- Patients who underwent robotic radical gastrectomy.
Exclusion
- Intraoperatively existing distant metastases
- Neoadjuvant chemotherapy
- Missing general and video data.
Key Trial Info
Start Date :
August 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT05999019
Start Date
August 1 2016
End Date
June 1 2023
Last Update
August 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.